(Q37892340)

24 August 2017

1 reference

title

Managing kidney disease with blood-pressure control (English)

1 reference

24 August 2017

1 reference

Elke Wühl

1

1 reference

24 August 2017

Franz Schaefer

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

21 June 2011

1 reference

Nature Reviews Nephrology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

434-444

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.73

24 August 2017

exact match

0 references

cites work

Proteinuria and the risk of developing end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Epidemiology of chronic renal failure in children: data from the ItalKid project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Adult hypertension and kidney disease: the role of fetal programming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Glomerular ultrafiltration and apical tubular action of IGF-I, TGF-beta, and HGF in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin II production and distribution in the kidney--II. Model-based analysis of experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Why are angiotensin concentrations so high in the kidney?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin II signal transduction: Stimulation of multiple mitogen-activated protein kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Sympathetic overactivity in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Sympathetic nerve activity in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Utility of 24-h ambulatory blood pressure measurement in a routine clinical setting of patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Prognostic value of circadian blood pressure variation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Understanding the nature of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Retarding progression of chronic renal disease: the neglected issue of residual proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Strict blood-pressure control and progression of renal failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Progression, remission, regression of chronic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Intensive blood-pressure control in hypertensive chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

ACE inhibitors and proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The incidence and implications of aldosterone breakthrough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Supramaximal dose of candesartan in proteinuric renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Management of glomerular proteinuria: a commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Bicarbonate supplementation slows progression of CKD and improves nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Role of calcium-phosphorous disorders in the progression of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

EPO: renoprotection beyond anemia correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Efficacy and safety of benazepril for advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Protein traffic activates NF-kB gene signaling and promotes MCP-1–dependent interstitial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Blood pressure and end-stage renal disease in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Progression of chronic renal failure in children with dysplastic kidneys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The endothelium in glomerular inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Tubular catabolism of albumin is associated with the release of an inflammatory lipid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin II production and distribution in the kidney: I. A kinetic model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin II increases the cytosolic calcium activity in rat podocytes in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Mechanisms underlying renoprotection during renin-angiotensin system blockade.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.73

Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan

31 March 2020

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

Treatment with carvedilol is associated with a significant reduction in microalbuminuria: a multicentre randomised study

1 reference

12 December 2020

Mechanism of angiotensin II-induced proteinuria in the rat

1 reference

12 December 2020

Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol.

1 reference

12 December 2020

Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN)

1 reference

12 December 2020

Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway.

1 reference

12 December 2020

Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?

1 reference

12 December 2020

Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?

1 reference

12 December 2020

Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy.

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation

1 reference

12 December 2020

Activities of cathepsins B and L in isolated nephron segments from proteinuric and nonproteinuric rats

1 reference

12 December 2020

"Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.73

1 reference

24 August 2017

1 reference